PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity

Jie Gao; Geng Kou; Hao Wang; Huaiwen Chen; Bohua Li; Ying Lü; Dapeng Zhang; Shu-Hui Wang; Sheng Hou; Weizhu Qian; Jianxin Dai; Jian Zhao; Yanqiang Zhong; Yajun Guo

doi:10.1007/s10549-008-0043-0

JOURNAL ARTICLE

PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity

Jie Gao Geng Kou Hao Wang Huaiwen Chen Bohua Li Ying Lü Dapeng Zhang Shu-Hui Wang Sheng Hou Weizhu Qian Jianxin Dai Jian Zhao Yanqiang Zhong Yajun Guo

Year: 2008 Journal: Breast Cancer Research and Treatment Vol: 115 (1)Pages: 29-41 Publisher: Springer Science+Business Media

DOI: 10.1007/s10549-008-0043-0

Get Full-Text PDF Get Analytical Report

Keywords:

Immunogenicity Pseudomonas exotoxin Chemistry PLGA Antibody Immunotoxin Cytotoxicity Pharmacology Breast cancer Toxicity Molecular biology In vitro Cancer Medicine Immunology Biochemistry Internal medicine Biology

Metrics

Cited By

1.89

FWCI (Field Weighted Citation Impact)

Refs

0.82

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Toxin Mechanisms and Immunotoxins

Life Sciences → Immunology and Microbiology → Immunology

Monoclonal and Polyclonal Antibodies Research

Health Sciences → Medicine → Radiology, Nuclear Medicine and Imaging

Bacteriophages and microbial interactions

Physical Sciences → Environmental Science → Ecology

PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity

Metrics

Citation History

Topics

Related Documents

Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy

Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes

Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity

Targeted tumor MRI with gadobutrol-loaded anti-HER2 immunoliposomes

Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity